logo
  

Woolworths Proposes To Buy Australian Pharmaceutical For A$1.75/shr

Woolworths Group (WOW.AX)) said Thursday that it has proposed to buy Australian Pharmaceutical Industries Limited or API for A$1.75 per API share in cash or total equity value of A$872 million.

The proposed offer price represents a premium of 20 cents per share or 12.9% over the price agreed between API and Wesfarmers under the scheme implementation deed announced on 8 November 2021.

Woolworths noted that the Board of API has determined that the Woolworths proposal is, or is reasonably likely to be, a superior proposal, as defined in the Wesfarmers Scheme Implementation Deed. Woolworths Group will engage constructively with API to quickly finalise its due diligence enquiries.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cargill, Inc., a privately held food company, is recalling certain chocolate products containing recalled Jif peanut butter due to the potential for salmonella contamination, the U.S. Food and Drug Administration said. The recall involves 795, 8-ounce boxes of Wilbur brand products, such as Milk and Dark Chocolate Covered Peanut Butter Ritz Crackers, Peanut Butter Meltaways... The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals, Inc.'s Dupixent (dupilumab) to treat eosinophilic esophagitis or EoE, a chronic immune disorder. It is the first FDA approval to treat EoE in adults and pediatric patients 12 years and older weighing at least 40 kilograms. Food products maker J. M. Smucker Co. has recalled select Jif peanut butter products sold in the United States due to potential Salmonella contamination, the U.S. Food and Drug Administration said. The recall involves various creamy, crunchy, natural, no added sugar, and reduced fat peanut butter, among others with lot codes 1274425 - 2140425.
Follow RTT